Core Insights - A novel RNA drug named TY1 has been confirmed to effectively activate the body's DNA repair mechanisms, offering new hope for the treatment of heart disease and autoimmune diseases [1][2] - The research, led by the Cedars-Sinai Medical Center, reveals a new method to heal the body without the use of stem cells, based on over 20 years of scientific research [1] - TY1 is a synthetic RNA molecule designed to enhance the activity of the TREX1 gene, which guides immune cells to clear damaged DNA fragments, promoting tissue repair and regeneration [1] Group 1 - TY1 has shown effectiveness in reversing tissue damage by increasing the number of immune cells capable of DNA repair, significantly reducing scar formation after heart attacks [1] - The drug also demonstrates efficacy in treating autoimmune diseases, indicating a new healing mechanism for various conditions [2] - The research team plans to advance TY1 into clinical trials to assess its safety and effectiveness in humans, paving the way for potential clinical applications [2]